Neuroscience

Neurological disorders can be rare and recruiting enough eligible participants for a study can be challenging. Moreover, due to the chronic or progressive nature of many conditions, retaining participants for the duration of the trial can be tough.

iNGENū CRO addresses this pain point with Enhanced Recruitment Strategies

iNGENū leverages a global network of research sites and patient advocacy groups, utilising advanced data analytics to target and recruit suitable participants efficiently. Through continuous patient engagement and education, we ensure high retention rates throughout our trials.

Neurological outcomes can be subjective and may require specialized scales or biomarkers. Ensuring consistency and reliability in endpoint measurements across different investigators and sites can be challenging.

iNGENū addresses this pain point with Standardization and Training

We implement standardised protocols for all endpoint assessments and provide intensive training for investigators and site personnel. By employing advanced digital tools, we ensure data consistency and reduce variability across sites.

Some neurological interventions, especially those that are invasive or novel, may carry significant risks. Monitoring for adverse events and ensuring participant safety is paramount.

iNGENū addresses this pain point with Rigorous Safety Protocols

We have established robust safety monitoring systems, with real-time data tracking and quick response mechanisms, ensuring the well-being of participants is prioritized at every stage.

Neurological disorders can manifest in various ways in different patients, making it difficult to group patients and interpret results.

iNGENū addresses this pain point with a Personalised Approach

Recognizing the diverse nature of neurological diseases, we employ stratification techniques and personalised medicine approaches. This helps in grouping patients more effectively and interpreting data in a more nuanced manner.

Many neurological disorders progress slowly, requiring long study durations to observe therapeutic effects or disease progression, which can be resource-intensive.

iNGENū addresses this pain point with Innovative Trial Designs

To counteract the long durations often required in neurological trials, we adopt adaptive trial designs, interim analyses, and predictive modeling. This not only accelerates the trial process but also optimizes the use of resources.